» Articles » PMID: 37661275

Relationship Between Arterial Stiffness, Left Ventricular Diastolic Function, and Renal Function in Chronic Kidney Disease

Overview
Journal BMC Nephrol
Publisher Biomed Central
Specialty Nephrology
Date 2023 Sep 3
PMID 37661275
Authors
Affiliations
Soon will be listed here.
Abstract

Aim: In chronic kidney disease, IgA nephropathy, and left ventricular diastolic dysfunction have prognostic significance as well. However, the relationship between diastolic dysfunction, arterial stiffness, and renal function has not been fully elucidated.

Methods: 79 IgA nephropathy patients (aged 46 ± 11 years) and 50 controls were investigated. Tissue Doppler imaging was used to measure early (Ea) and late (Aa) diastolic velocities. Arterial stiffness was measured by a photoplethysmographic (stiffness index (SI)) and an oscillometric method (aortic pulse wave velocity (PWVao)).

Results: We compared the IgAN patients to a similar cardiovascular risk group with a preserved eGFR. A strong correlation was found between Ea/Aa and SI (p < 0.001), also with PWVao (p < 0.001), just in IgAN, and with eGFR (p < 0.001) in both groups. IgAN patients were divided into groups CKD1-2 vs. CKD3-5. In the CKD 3-5 group, the incidence of diastolic dysfunction increased significantly: 39% vs. 72% (p = 0.003). Left ventricle rigidity (LVR) was calculated, which showed a close correlation with SI (p = 0.009) and eGFR (p = 0.038). By linear regression analysis, the independent predictors of SI were age, E/A, and E/Ea; SI was the predictor of LVR; and E/A and hypertension were the predictors of eGFR.

Conclusion: In chronic kidney disease, increased cardiac rigidity and vascular stiffness coexist with decreased renal function, which is directly connected to diastolic dysfunction and vascular stiffness. On the basis of comparing the CKD group to the control group, vascular alterations in very early CKD can be identified.

Citing Articles

Emerging regulatory mechanisms and functions of biomolecular condensates: implications for therapeutic targets.

Jeon S, Jeon Y, Lim J, Kim Y, Cha B, Kim W Signal Transduct Target Ther. 2025; 10(1):4.

PMID: 39757214 PMC: 11701242. DOI: 10.1038/s41392-024-02070-1.


Investigating the cause of cardiovascular dysfunction in chronic kidney disease: capillary rarefaction and inflammation may contribute to detrimental cardiovascular outcomes.

Beikoghli Kalkhoran S, Basalay M, He Z, Golforoush P, Roper T, Caplin B Basic Res Cardiol. 2024; 119(6):937-955.

PMID: 39472324 PMC: 11628583. DOI: 10.1007/s00395-024-01086-6.


Does Metabolic Syndrome and Its Components Have Prognostic Significance for Renal and Cardiovascular Outcomes in IgA Nephropathy?.

Sagi B, Vas T, Csiky B, Nagy J, Kovacs T Biomedicines. 2024; 12(6).

PMID: 38927457 PMC: 11201004. DOI: 10.3390/biomedicines12061250.

References
1.
Cameli M, Lembo M, Sciaccaluga C, Bandera F, Ciccone M, DAndrea A . Identification of cardiac organ damage in arterial hypertension: insights by echocardiography for a comprehensive assessment. J Hypertens. 2019; 38(4):588-598. DOI: 10.1097/HJH.0000000000002323. View

2.
Khouri S, Maly G, Suh D, Walsh T . A practical approach to the echocardiographic evaluation of diastolic function. J Am Soc Echocardiogr. 2004; 17(3):290-7. DOI: 10.1016/j.echo.2003.08.012. View

3.
Zanoli L, Lentini P, Briet M, Castellino P, House A, London G . Arterial Stiffness in the Heart Disease of CKD. J Am Soc Nephrol. 2019; 30(6):918-928. PMC: 6551785. DOI: 10.1681/ASN.2019020117. View

4.
Chow B, Rabkin S . The relationship between arterial stiffness and heart failure with preserved ejection fraction: a systemic meta-analysis. Heart Fail Rev. 2015; 20(3):291-303. DOI: 10.1007/s10741-015-9471-1. View

5.
Liang H, Hsiao Y, Yeh H, Ting I, Lin C, Chiang H . Associations between Myocardial Diastolic Dysfunction and Cardiovascular Mortality in Chronic Kidney Disease: A Large Single-Center Cohort Study. J Am Soc Echocardiogr. 2021; 35(4):395-407. DOI: 10.1016/j.echo.2021.12.003. View